Massachusetts Cannabis Market Set to Increase Due to Increased Demand | Financial Buzz

Massachusetts Cannabis Market Set to Increase Due to Increased Demand

CLS Holdings USA, Inc. (OTCQB: CLSH) announced on Wednesday plans to acquire 80 percent ownership interest in CannAssist LLC. The partnership further advances CLS in the rapidly expanding market in Massachusetts.

Jeff Binder, Chief Executive Officer of CLS Holdings USA said in a recent press release, “The market dynamics in Massachusetts are compelling for large scale cultivation. The current cultivation in Mass is approximately 800k square feet, while demand is expected to exceed 8,000,000 square feet.”

Massachusetts is ideally positioned for many cannabis cultivators looking to expand in the quickly growing industry. The state hosts a population of 6.9 million people and is with in a 100-mile radius from Rhode Island, Connecticut, New York, New Hampshire and Vermont. With less than 50 dispensaries in the entire state, the room for growth is sizeable.

Last year Massachusetts brought in USD 106,218,199 Million of legal cannabis sales. By 2021, medical sales in the state are expected to increase to USD 238,400,000 Million. While adult use sales are anticipated to grow to USD 929,300,000 Million the same year.

With very few dispensaries across the state and none located in Boston, the supply and demand of cannabis could be unproportionate. Since the inception of recreational use of cannabis in Massachusetts, it has faced many regulations and limitations.

Under the Cannabis Control Commission (CCC) there can be a maximum of 75 cultivators In Massachusetts up until October 2019, with no limit after that. The CCC limits each cannabis producer to 100,000 square feet of property for cultivation.

Obtaining a license for cultivation in the state requires an initial application fee of up to USD 3,000, while the license for a marijuana cultivator costs up to USD 15,000 and a license for a marijuana testing facility can cost up to USD 10,000.

CLS’s partnership with CannAssist optimally positions them to become a “significant entity” in the Massachusetts cannabis market.

Ontario-based CannAssist is a producer of pharmaceutical grade cannabis for medical use. The Company has applied for a state cultivation grow license with the City of Leicester, for plans to execute a 86,000 square foot facility on 88 Huntoon Memorial Highway. At that size the facility will become one of the top three facilities in Massachusetts. It is expected to produce its first harvest in the first quarter of 2020, yielding 28,000 pounds of flower along with 240,000 grams of extract.

CLS is expecting to generate substantial positive cash flow from the facility, as total revenues are anticipated to surpass USD 100 Million. Jeff Binder continued to comment on the partnership,“This opportunity fits into our stated objective of entering markets that are on the cusp of implementing a robust adult use market.”

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For cls holdings usa inc. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: